ClinicalTrials.Veeva

Menu

Utility of PCD Diagnostics to Improve Clinical Care

Vanderbilt University Medical Center logo

Vanderbilt University Medical Center

Status

Enrolling

Conditions

Primary Ciliary Dyskinesia

Treatments

Other: nNO testing

Study type

Interventional

Funder types

Other

Identifiers

NCT03704207
IRB #160951

Details and patient eligibility

About

This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.

Full description

This study is a prospective data collection of individuals referred to the investigators clinical center for considerations of PCD. Participants sign informed consent to have clinical information entered into a secure electronic database. As part of this study, participants may have nasal nitric oxide (nNO) testing performed. nNO testing is a research procedure, but it is a test with growing utility for making a diagnosis of PCD when performed in the right clinical setting.

Enrollment

200 estimated patients

Sex

All

Ages

1+ year old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Referred to center for PCD diagnosis considerations
  • Ability to perform study procedures
  • Age greater than 2 years of age

Exclusion criteria

  • Age less than 2 years of age Inability to perform informed consent

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

Nasal Nitric Oxide testing and collection of clinical data
Other group
Description:
Participants will have nNO testing is indicated. All participants in this study have some basic clinical data collected at time of enrollment. Participants with a confirmed diagnosis of PCD or in those participants with a working diagnosis of PCD in which ongoing nNO testing is performed have prospective data collection. Some participants have a confirmed diagnosis of PCD by genetics or ciliary biopsy at time of study entry and thus do not need nNO testing, but are followed prospectively with collection of basic clinical data
Treatment:
Other: nNO testing

Trial contacts and locations

1

Loading...

Central trial contact

Michael O'Connor, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems